| Literature DB >> 26603921 |
Osman A Dar1, Rumina Hasan2, Jørgen Schlundt3, Stephan Harbarth4, Grazia Caleo5, Fazal K Dar6, Jasper Littmann7, Mark Rweyemamu8, Emmeline J Buckley9, Mohammed Shahid10, Richard Kock11, Henry Lishi Li9, Haydar Giha6, Mishal Khan12, Anthony D So13, Khalid M Bindayna6, Anthony Kessel9, Hanne Bak Pedersen14, Govin Permanand14, Alimuddin Zumla15, John-Arne Røttingen16, David L Heymann17.
Abstract
The effectiveness of existing policies to control antimicrobial resistance is not yet fully understood. A strengthened evidence base is needed to inform effective policy interventions across countries with different income levels and the human health and animal sectors. We examine three policy domains-responsible use, surveillance, and infection prevention and control-and consider which will be the most effective at national and regional levels. Many complexities exist in the implementation of such policies across sectors and in varying political and regulatory environments. Therefore, we make recommendations for policy action, calling for comprehensive policy assessments, using standardised frameworks, of cost-effectiveness and generalisability. Such assessments are especially important in low-income and middle-income countries, and in the animal and environmental sectors. We also advocate a One Health approach that will enable the development of sensitive policies, accommodating the needs of each sector involved, and addressing concerns of specific countries and regions.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26603921 DOI: 10.1016/S0140-6736(15)00520-6
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321